Literature DB >> 9759693

Ischemic colitis and sumatriptan use.

J F Knudsen1, B Friedman, M Chen, J E Goldwasser.   

Abstract

Sumatriptan succinate, a serotonin-1 (5-hydroxytryptamine-1) receptor agonist, is an antimigraine drug that is reported to act by selectively constricting intracranial arteries. Recently, vasopressor responses that are distinct from the cranial circulation have been demonstrated to occur in the systemic, pulmonary, and coronary circulations. Cases have been published of coronary vasospasm, myocardial ischemia, and myocardial infarction occurring after sumatriptan use. We report on the development of 8 serious cases of ischemic colitis in patients with migraine treated with sumatriptan.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759693     DOI: 10.1001/archinte.158.17.1946

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  Sumatriptan-associated ischemic colitis.

Authors:  Mohit Naik; Rajendra Potluri; Eyad Almasri; George L Arnold
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

2.  A case of sumatriptan-induced intestinal ischemia.

Authors:  Aparna Repaka; Julius Wenger; Shanthi V Sitaraman
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

3.  A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.

Authors:  Kenneth Tong; Jean Paul Nicandro; Reshma Shringarpure; Emil Chuang; Lin Chang
Journal:  Therap Adv Gastroenterol       Date:  2013-09       Impact factor: 4.409

4.  Ischemic colitis: clinical presentation, localization in relation to risk factors, and long-term results.

Authors:  Philippe M Glauser; Petra Wermuth; Gieri Cathomas; Evelyn Kuhnt; Samuel A Käser; Christoph A Maurer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 5.  Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS.

Authors:  Thuc Quyen Nguyen; James H Lewis
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

Review 6.  [Clinical use of triptans in the management of migraine].

Authors:  Michel Lantéri-Minet
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Tolerability of the triptans: clinical implications.

Authors:  Giuseppe Nappi; Giorgio Sandrini; Grazia Sances
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Ischemic Colitis as a Complication of Medication Use: An Analysis of the Federal Adverse Event Reporting System.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2016-04-12       Impact factor: 3.199

9.  Bilateral Renal Infarctions During the Use of Sumatriptan.

Authors:  Blaise Abramovitz; Amanda Leonberg-Yoo; Jehan Z Bahrainwala; Harold Litt; Michael R Rudnick
Journal:  Kidney Int Rep       Date:  2018-05-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.